Literature DB >> 22806406

Following the concentration of polymeric nanoparticles during nebulization.

Moritz Beck-Broichsitter1, Marie-Christine Knuedeler, Thomas Schmehl, Werner Seeger.   

Abstract

PURPOSE: Nebulization represents one strategy to achieve pulmonary deposition of biodegradable nanoparticles. Besides stability as a key requirement to maintain functionality, the output of nanoparticles from the nebulizer needs to be considered to facilitate an efficient pulmonary therapy.
METHODS: Formulations nebulized by air-jet and vibrating-membrane technology were analyzed for their aerodynamic characteristics by laser diffraction. The nebulization stability of poly(D,L-lactide-co-glycolide) nanoparticles was assessed by dynamic light scattering. Moreover, several methods were employed to account for the shift in solute and NP reservoir concentration during nebulization.
RESULTS: Regardless of the formulation or nebulizer used generated aerosols all showed aerodynamic characteristics suitable for deep lung deposition. However, nanoparticles were prone to aggregation and concentrated during air-jet nebulization. The particle concentration effect was significantly pronounced in comparison to molecular solutes under the same nebulization conditions, due to nanoparticle aggregation and subsequent particle remainder in the reservoir. In contrast, vibrating-membrane technology did not affect nanoparticle integrity and reservoir concentration during nebulization, as the unaffected submicron particles passed through the tapered holes of the actuated plate.
CONCLUSIONS: Aggregation and concentration effects during air-jet nebulization emphasize that nanosuspensions should preferably be delivered with a suitable vibrating-membrane device in order to ensure an effective pulmonary application.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806406     DOI: 10.1007/s11095-012-0819-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  33 in total

1.  Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.

Authors:  Lea Ann Dailey; Thomas Schmehl; Tobias Gessler; Matthias Wittmar; Friedrich Grimminger; Werner Seeger; Thomas Kissel
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

2.  Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens.

Authors:  Moritz Beck-Broichsitter; Marcel Thieme; Juliane Nguyen; Thomas Schmehl; Tobias Gessler; Werner Seeger; Seema Agarwal; Andreas Greiner; Thomas Kissel
Journal:  Macromol Biosci       Date:  2010-09-07       Impact factor: 4.979

Review 3.  Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers.

Authors:  Jolyon P Mitchell; Mark W Nagel; Steve Nichols; Ola Nerbrink
Journal:  J Aerosol Med       Date:  2006

4.  New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

Authors:  Joseph S Lass; Andrew Sant; Martin Knoch
Journal:  Expert Opin Drug Deliv       Date:  2006-09       Impact factor: 6.648

Review 5.  Current therapies and technological advances in aqueous aerosol drug delivery.

Authors:  Alan B Watts; Jason T McConville; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2008-09       Impact factor: 3.225

6.  Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.

Authors:  Moritz Beck-Broichsitter; Julia Gauss; Claudia B Packhaeuser; Kerstin Lahnstein; Thomas Schmehl; Werner Seeger; Thomas Kissel; Tobias Gessler
Journal:  Int J Pharm       Date:  2008-09-19       Impact factor: 5.875

7.  Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.

Authors:  J C Waldrep; R Dhand
Journal:  Curr Drug Deliv       Date:  2008-04       Impact factor: 2.565

8.  Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles.

Authors:  Moritz Beck-Broichsitter; Julia Gauss; Tobias Gessler; Werner Seeger; Thomas Kissel; Thomas Schmehl
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-02       Impact factor: 2.849

9.  Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery.

Authors:  Jean C Sung; Danielle J Padilla; Lucila Garcia-Contreras; Jarod L Verberkmoes; David Durbin; Charles A Peloquin; Katharina J Elbert; Anthony J Hickey; David A Edwards
Journal:  Pharm Res       Date:  2009-04-30       Impact factor: 4.200

10.  Inhaled iloprost for severe pulmonary hypertension.

Authors:  Horst Olschewski; Gerald Simonneau; Nazzareno Galiè; Timothy Higenbottam; Robert Naeije; Lewis J Rubin; Sylvia Nikkho; Rudolf Speich; Marius M Hoeper; Jürgen Behr; Jörg Winkler; Olivier Sitbon; Wladimir Popov; H Ardeschir Ghofrani; Alessandra Manes; David G Kiely; Ralph Ewert; Andreas Meyer; Paul A Corris; Marion Delcroix; Miguel Gomez-Sanchez; Harald Siedentop; Werner Seeger
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  2 in total

Review 1.  Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.

Authors:  Caleb F Anderson; Maria E Grimmett; Christopher J Domalewski; Honggang Cui
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-10

2.  Nebulised Gadolinium-Based Nanoparticles for a Multimodal Approach: Quantitative and Qualitative Lung Distribution Using Magnetic Resonance and Scintigraphy Imaging in Isolated Ventilated Porcine Lungs.

Authors:  Yoann Montigaud; Jérémie Pourchez; Lara Leclerc; Olivier Tillement; Anthony Clotagatide; Clémence Bal; Noël Pinaud; Nobuyasu Ichinose; Bei Zhang; Sophie Perinel; François Lux; Yannick Crémillieux; Nathalie Prevot
Journal:  Int J Nanomedicine       Date:  2020-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.